Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study.
about
The opioid epidemic and neonatal abstinence syndrome in the USA: a review of the continuum of care.Identification of smoking using Medicare data--a validation study of claims-based algorithmsTreating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National GuidanceOpioid use during pregnancy: a population-based cohort study.Birth and Neonatal Outcomes Following Opioid Use in Pregnancy: A Danish Population-Based Study.Zidovudine use in pregnancy and congenital malformations.Consequences of prenatal opioid use for newborns.Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study.Antipsychotic Medication Use Among Publicly Insured Pregnant Women in the United States.Comparison of Time to First Dose of Oral Morphine in the Treatment of Neonatal Abstinence Syndrome.Nonmedical Use of Prescription Opioids among Pregnant U.S. Women.Transmission of risk from parents with chronic pain to offspring: an integrative conceptual model.Neonatal Abstinence Syndrome: Trend and Expenditure in Louisiana Medicaid, 2003-2013.Opioid Use Disorder in Pregnancy.Epidemiological Evidence for a Decreasing Incidence of Neonatal Abstinence Syndrome, 2000-11.Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida.Angiotensin-Converting Enzyme Inhibitors and the Risk of Congenital Malformations.Late Pregnancy β Blocker Exposure and Risks of Neonatal Hypoglycemia and Bradycardia.Simplification of the Finnegan Neonatal Abstinence Scoring System: retrospective study of two institutions in the USA.Decreasing Total Medication Exposure and Length of Stay While Completing Withdrawal for Neonatal Abstinence Syndrome during the Neonatal Hospital StayMethadone versus buprenorphine for opioid use dependence and risk of neonatal abstinence syndrome.Review of Post-Marketing Safety Data on Tapentadol, a Centrally Acting Analgesic.Placental Complications Associated With Psychostimulant Use in Pregnancy.Maternal buprenorphine treatment and infant outcome.The Role of Preterm Birth in the Association Between Opioid Maintenance Therapy and Neonatal Abstinence Syndrome.Neonatal abstinence syndrome: an update.Analysis of the factors that influence the Finnegan Neonatal Abstinence Scoring System.Commentary on Gibson et al. (2017): Gestational age and the severity of neonatal abstinence syndrome.The Epidemic of Neonatal Abstinence Syndrome, Historical References of Its' Origins, Assessment, and Management.Early life stress and environmental influences on the neurodevelopment of children with prenatal opioid exposureCYP450 genotype and pharmacogenetic association studies: a critical appraisal
P2860
Q30239085-3838EB98-2055-4269-8278-E37A3B59D81AQ31036793-E49A20A8-308A-4E36-90E5-E4E73F87614CQ33760424-4F983B01-6138-476E-9F92-F65DDAF54906Q33875076-B3180233-9AA1-4220-9648-1A70FFE369B7Q36142245-8AA5031C-0570-46EC-863C-326E389C13EDQ36379162-3064026C-BFFA-4116-8A24-2F8A37AD257FQ38547160-AF785E4E-761E-40F1-9B20-3A4835C74F26Q38646134-D79FE1C4-53B9-4909-9B43-E4B2FFEFA2C0Q38724641-C7F2D11C-091A-47FE-A288-608A96B1EE43Q38788360-3ACC4BA4-AA14-4F0A-BA02-F13DEE46D82BQ38837808-3B022CBE-8B16-4F3F-A7F2-9C57D4F2C04FQ38845051-07AFF872-8479-4953-B173-2B1DEE0EBD22Q38974923-6E05E604-0337-4D20-A92C-BBBAA345F408Q39340617-5E2AF16C-DD1F-48A4-88BA-22A53B7927A2Q40020329-6812B1B8-E0C1-4CE6-944E-A16E76C0D085Q40202958-13D84E83-6AA5-4761-8FA4-E4AC87056B6CQ40437479-A6C7C961-5303-48A4-8C42-51E9E88B1148Q40601235-40942172-5A7E-4AA0-BB4E-F530469914B6Q42172730-3F0938BB-577B-4465-BF59-147863C1AA2CQ42700561-1E0DA6B3-3406-4495-8DB0-3DEA01F7AF11Q44350531-F818E793-A177-40C5-9599-D1FC191CC117Q47261672-3D6553B6-983D-4378-8F80-465772E5D0C2Q47616895-095972DA-7873-4D1E-992A-A89CA26C9460Q47712360-536B0F0A-863C-4F22-9700-3F3FCB7CAFAFQ48160111-3A925584-184C-43A9-AACD-16D02E04091EQ49966520-8F680A8C-E371-4CDD-BB3E-45B935D05FEAQ50746005-765A7294-68D2-4545-B302-E78BED65141AQ52312251-4955C6A9-C01D-4EF1-85BC-C5F5BEB306E9Q52665558-CDBF5746-F24D-457F-9FE5-D33D55C931E6Q57169315-C3D9BC8D-70B7-4406-ACCD-9C00CEFED3CDQ57585515-A49F9403-D198-448E-BC01-71969A7F839A
P2860
Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Exposure to prescription opioi ...... population based cohort study.
@ast
Exposure to prescription opioi ...... population based cohort study.
@en
type
label
Exposure to prescription opioi ...... population based cohort study.
@ast
Exposure to prescription opioi ...... population based cohort study.
@en
prefLabel
Exposure to prescription opioi ...... population based cohort study.
@ast
Exposure to prescription opioi ...... population based cohort study.
@en
P2093
P2860
P356
P1433
P1476
Exposure to prescription opioi ...... population based cohort study.
@en
P2093
Brian T Bateman
Elisabetta Patorno
Helen Mogun
Karol Kaltenbach
Krista F Huybrechts
Leslie S Kerzner
Sonia Hernandez-Diaz
P2860
P356
10.1136/BMJ.H2102
P407
P577
2015-05-14T00:00:00Z